CSL - Equity Capital And Reserves


CSL reported $18.66B in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Arca Biopharma USD 1.11B 627.83M Jun/2026
aTyr Pharma USD 48.79M 9.15M Jun/2026
Bio Path USD -8.49M 482K Mar/2026
Brainstorm Cell Therapeutics USD -11.6M 588K Jun/2026
Cara Therapeutics USD 14.5M 6.44M Mar/2026
CSL USD 18.66B 2.75B Dec/2025
Curis USD 12.71M 7.24M Mar/2026
Immunic USD 151.23M 157.91M Mar/2026
Minerva Neurosciences USD -140.75M 106.17M Dec/2025
Sangamo BioSciences USD 19.6M 14.7M Jun/2025
TherapeuticsMD USD 27.67M 990K Jun/2024